Profil
Michael Franken is the founder of Momenta Pharmaceuticals, Inc., Radius Health, Inc. He is currently the Chief Executive Officer at Red Oak Medicines, Inc. and the Chief Business Officer at LogicBio Therapeutics, Inc. His former positions include VP & General Manager-Solid Organ Transplantation at Genzyme Corp., Life Sciences Business Consultant at Wilkerson Group, and Principal at Sanofi Ventures.
He holds a graduate degree from Harvard University and a doctorate from Ruprecht-Karls-Universität Heidelberg.
Aktive Positionen von Michael Franken
| Unternehmen | Position | Beginn |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | 01.07.2021 |
Red Oak Medicines, Inc.
Red Oak Medicines, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Michael Franken
| Unternehmen | Position | Ende |
|---|---|---|
| RADIUS HEALTH, INC. | Gründer | - |
| MOMENTA PHARMACEUTICALS, INC. | Gründer | - |
Wilkerson Group
Wilkerson Group Medical/Nursing ServicesHealth Services Consulting services to pharmaceutical and medical products industry | Corporate Officer/Principal | - |
Sanofi Ventures
Sanofi Ventures Investment ManagersFinance Sanofi Ventures nvests in companies located in the United States. The firm targets companies operating in the fields of biotech and digital health. t provides financing for seed and early stage capital requirements. It acts as lead investor and also takes a seat on board of directors. | Corporate Officer/Principal | - |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
Ausbildung von Michael Franken
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wilkerson Group
Wilkerson Group Medical/Nursing ServicesHealth Services Consulting services to pharmaceutical and medical products industry | Health Services |
Ruprecht-Karls-Universität Heidelberg
Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi Ventures
Sanofi Ventures Investment ManagersFinance Sanofi Ventures nvests in companies located in the United States. The firm targets companies operating in the fields of biotech and digital health. t provides financing for seed and early stage capital requirements. It acts as lead investor and also takes a seat on board of directors. | Finance |
LogicBio Therapeutics, Inc.
LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases | Health Technology |
Red Oak Medicines, Inc.
Red Oak Medicines, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
















